CRISPR

CRISPR1-bcar1

ID

ZDB-CRISPR-210422-8

Name

CRISPR1-bcar1

Previous Names

None

Target

bcar1 (1)

Sequence

5' - GTGCTGGAGCGGGACACGCA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
u7000	bcar1

Expression

Gene expression in Wild Types + CRISPR1-bcar1

No data available

Phenotype

Phenotype resulting from CRISPR1-bcar1

No data available

Phenotype of all Fish created by or utilizing CRISPR1-bcar1

Phenotype	Fish	Conditions	Figures
whole organism decreased length, abnormal	bcar1^u7000/u7000	standard conditions	Fig. S3 from Wisniewski et al., 2020
fin Ab1-bcar1 labeling absent, abnormal	bcar1^u7000/u7000	standard conditions	Fig. S2 from Wisniewski et al., 2020
post-vent region Ab1-bcar1 labeling decreased distribution, abnormal	bcar1^u7000/u7000	standard conditions	Fig. S2 from Wisniewski et al., 2020
whole organism Ab1-bcar1 labeling absent, abnormal	bcar1^u7000/u7000	standard conditions	Fig. S2 from Wisniewski et al., 2020
post-vent region Ab1-bcar1 labeling decreased amount, abnormal	bcar1^u7000/u7000	standard conditions	Fig. S2 from Wisniewski et al., 2020
trunk lymphangiogenesis decreased process quality, abnormal	bcar1^u7000/u7000; hu7135Tg; um13Tg	standard conditions	Fig. S5 from Wisniewski et al., 2020
caudal vein plexus angiogenesis decreased process quality, abnormal	bcar1^u7000/u7000; um13Tg; y7Tg	standard conditions	Figure 2 from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal	bcar1^u7000/u7000; um13Tg; y7Tg	standard conditions	Figure 2 from Wisniewski et al., 2020
caudal vein plexus structure, abnormal	bcar1^u7000/u7000; y1Tg	chemical treatment: PP2	Figure 6 from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal	bcar1^u7000/u7000; y1Tg	chemical treatment: SU6656	Figure 6 from Wisniewski et al., 2020
caudal vein plexus structure, abnormal	bcar1^u7000/u7000; y1Tg	chemical treatment: SU6656	Figure 6 from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal	bcar1^u7000/u7000; y1Tg	chemical treatment: PP2	Figure 6 from Wisniewski et al., 2020
caudal vein plexus structure, abnormal	bcar1^u7000/u7000; y1Tg	control	Figure 6 from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal	bcar1^u7000/u7000; y1Tg	standard conditions	Figure 2 , Figure 3 , Figure 6 from Wisniewski et al., 2020
caudal vein plexus angiogenesis decreased process quality, abnormal	bcar1^u7000/u7000; y1Tg	standard conditions	Figure 2 from Wisniewski et al., 2020

Citations